GlassScriptPhysician profile
Charles T Zenzen
NPI 1265448930
$2,799.90
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.29 · 2020: $666 · 2021: $853 · 2022: $739 · 2023: $314 · 2024: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,109.84 | 2020-2024 | Argos |
| New World Medical,INC. | $359.02 | 2020-2023 | |
| Bausch & Lomb Americas INC. | $245.49 | 2022-2024 | Miebo, Xiidra, Vyzulta |
| Kala Pharmaceuticals, INC. | $245.30 | 2020-2021 | |
| Oyster Point Pharma, INC. | $149.34 | 2022-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $126.99 | 2019-2021 | |
| Glaukos Corporation | $123.00 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $86.55 | 2024 | Xdemvy |
| Allergan, INC. | $73.39 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $59.04 | 2020-2022 | |
| Abbvie INC. | $48.42 | 2022-2023 | Alphagan P, Vuity, Lumigan |
| Sun Pharmaceutical Industries INC. | $38.95 | 2020-2022 | |
| Ocular Therapeutix, INC. | $32.50 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $26.73 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Rxsight INC | $23.94 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $17.91 | 2022 | |
| Horizon Therapeutics Plc | $14.45 | 2021 | |
| Aerie Pharmaceuticals, INC. | $12.38 | 2021 | |
| Tearlab Corp | $6.66 | 2023 | Tearlab Osmolarity System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Zenzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.